Elevance Health (ELV) Stock Price, News & Analysis

Company Overview

Elevance Health, Inc. (NYSE: ELV) is a health benefits and services company that provides health insurance, managed care and related healthcare solutions in the United States. Its offerings serve individuals, employers, government-sponsored programs and other organizations across commercial, Medicare and Medicaid markets.

The company operates a portfolio of health plans, including Blue Cross Blue Shield-affiliated plans in several states, as well as government-focused plans marketed under brands such as Wellpoint. Through its Carelon businesses, Elevance Health also provides pharmacy services, behavioral health support, care delivery, healthcare analytics and other solutions intended to help coordinate and manage patient care.

Elevance Health was formerly known as Anthem, Inc. and adopted its current name in 2022 to reflect the company’s broader healthcare strategy beyond traditional health insurance. The company is led by President and Chief Executive Officer Gail K. Boudreaux and primarily serves customers and members throughout the United States.

Key Stats

• Today's Range: $390.00 to $395.44
• 50-Day Range: $375.44 to $424.78
• 52-Week Range: $274.84 to $436.24
• Volume: 934,755 shs
• Average Volume: 1.20 million shs
• Market Capitalization: $85.11 billion
• P/E Ratio: 17.44
• Dividend Yield: 1.75%
• Price Target: $440.90
• Consensus Rating: Moderate Buy

Elevance Health Stock Analysis - MarketRank™

Elevance Health scored higher than 90% of companies evaluated by MarketBeat, and ranked 34th out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Elevance Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.65, and is based on no strong buy ratings, 15 buy ratings, 8 hold ratings, and no sell ratings.

Upside Potential

Elevance Health has a consensus price target of $440.90, representing about 12.3% upside from its current price of $392.45.

Amount of Analyst Coverage

Elevance Health has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 7.87%

Earnings Growth

Earnings for Elevance Health are expected to grow by 7.87% in the coming year, from $27.18 to $29.32 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Elevance Health is 17.44, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.45.

Price to Earnings Ratio vs. Sector

The P/E ratio of Elevance Health is 17.44, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 273.78.

Price to Earnings Growth Ratio

Elevance Health has a PEG Ratio of 2.05. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Elevance Health has a P/B Ratio of 1.98. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.47% of the float of Elevance Health has been sold short.

Short Interest Ratio / Days to Cover

Elevance Health has a short interest ratio ("days to cover") of 4.21.

Change versus previous month

Short interest in Elevance Health has recently decreased by 2.74%, indicating that investor sentiment is improving.

Dividend

• Score: 4.2 / 5
• Dividend Strength: Strong

Dividend Yield

Elevance Health pays a meaningful dividend of 1.74%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Elevance Health has been increasing its dividend for 14 years.

Dividend Coverage

The dividend payout ratio of Elevance Health is 30.58%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Elevance Health will have a dividend payout ratio of 23.47% next year. This indicates that Elevance Health will be able to sustain or increase its dividend.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 1.34

News Sentiment

Elevance Health has a news sentiment score of 1.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.75 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Elevance Health this week, compared to 8 articles on an average week.

Search Interest

Only 7 people have searched for ELV on MarketBeat in the last 30 days. This is a decrease of -30% compared to the previous 30 days.

MarketBeat Follows

Only 5 people have added Elevance Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Elevance Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.34% of the stock of Elevance Health is held by insiders.

Percentage Held by Institutions

89.24% of the stock of Elevance Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 7/15/2026
• Record date for 9/25 Dividend: 9/10/2026
• Ex-Dividend for 9/25 Dividend: 9/10/2026
• Dividend Payable: 9/25/2026
• Today: 9/29/2026
• Next Earnings (Estimated): 10/21/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Managed Healthcare
• Current Symbol: NYSE:ELV
• CIK: 1156039
• Web: www.elevancehealth.com
• Phone: (800) 331-1476
• Fax: 317-488-6275
• Employees: 97,100
• Year Founded: 1944

Price Target and Rating

• Average Price Target for Elevance Health: $440.90
• High Price Target: $498.00
• Low Price Target: $360.00
• Potential Upside/Downside: +12.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.65
• Research Coverage: 23 Analysts

Profitability

• EPS (Trailing Twelve Months): $22.50
• Trailing P/E Ratio: 17.44
• Forward P/E Ratio: 14.44
• P/E Growth: 2.05
• Net Income: $5.66 billion
• Net Margins: 2.47%
• Pretax Margin: 2.91%
• Return on Equity: 14.64%
• Return on Assets: 5.22%

Debt

• Debt-to-Equity Ratio: 0.68
• Current Ratio: 1.52
• Quick Ratio: 1.52

Sales & Book Value

• Annual Sales: $201.11 billion
• Price / Sales: 0.42
• Cash Flow: $37.38 per share
• Price / Cash Flow: 10.50
• Book Value: $198.10 per share
• Price / Book: 1.98

Miscellaneous

• Outstanding Shares: 216,869,000
• Free Float: 216,132,000
• Market Cap: $85.11 billion
• Optionable: Optionable
• Beta: 0.69